| Description |
Why Attend:
* Learn the current issues facing drug manufacturers in Europe and North America in regard to pricing and reimbursement
* Better understand the trends of generic pricing in Europe
* Learn from experts on how to effectively price products in the EU and North America
* Determine key strategies to assist in the management of pricing and reimbursement in an increasing globalising world
* Network with leaders from regulatory agencies, pharma-biotech and healthcare industries
Conference Topics and Confirmed Speakers
--Pricing of Pharmaceuticals in Europe--
Dr Jorge Mestre-Ferrandiz, Senior Economist, Office of Health Economics, Whitehall, London, UK
---Comparative Assessment of Generic Medicines---
Professor Steven Simoens, Research Centre for Pharmaceutical Care and Pharmaco-economics, Katholieke Universiteit Leuven, Belgium
---NICE and Risk Sharing/Capping Schemes---
Dr Kalipso Chalkidou, Associate Director of Research and Development, National Institute for Clinical Effectiveness, London, UK
---Health Economics in the Era of Biologics---
Mr Ulf Staginnus, Associate Director Outcomes Research Iberia and EMEA, Spain
---Managing the Complexity of Pricing and Reimbursement in a Globalizing World---
Dr Dieter Russmann, Vice President Global Customer Strategy, Service Leader, Pricing & Reimbursement Europe, PAREXEL Consulting, Germany
Who Should Attend
Individuals from the following industries:
* Regulatory Agency Executives
* Pharmaceutical companies
* Biotechnology companies
* Specialty pharmaceutical companies
* Medical device manufacturers
* Investment and capital markets community
Individuals from the following areas/departments will greatly benefit from attending:
* Executive management
* Corporate development
* Regulatory executives
* Pricing executives
* Commercial development executives
* New product planning executives
* Legal professionals
* Licensing personnel
* Intellectual property specialists
* Strategic planning & development
* Marketing executives
* R&D executives
|
|
